| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.47 | 0.0006 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.0007 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |